192 related articles for article (PubMed ID: 8005664)
1. Induction of tumor necrosis factor alpha by the group- and type-specific polysaccharides from type III group B streptococci.
Mancuso G; Tomasello F; von Hunolstein C; Orefici G; Teti G
Infect Immun; 1994 Jul; 62(7):2748-53. PubMed ID: 8005664
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of interleukin-6 in neonatal mouse models of group B streptococcal disease.
Mancuso G; Tomasello F; Migliardo M; Delfino D; Cochran J; Cook JA; Teti G
Infect Immun; 1994 Nov; 62(11):4997-5002. PubMed ID: 7927780
[TBL] [Abstract][Full Text] [Related]
3. Cytokine appearance and effects of anti-tumor necrosis factor alpha antibodies in a neonatal rat model of group B streptococcal infection.
Teti G; Mancuso G; Tomasello F
Infect Immun; 1993 Jan; 61(1):227-35. PubMed ID: 8418044
[TBL] [Abstract][Full Text] [Related]
4. Role of group B streptococcal capsular polysaccharides in the induction of septic arthritis.
Tissi L; von Hunolstein C; Bistoni F; Marangi M; Parisi L; Orefici G
J Med Microbiol; 1998 Aug; 47(8):717-23. PubMed ID: 9877193
[TBL] [Abstract][Full Text] [Related]
5. Production of tumor necrosis factor-alpha and interleukin-6 in mice infected with group B streptococci.
Teti G; Mancuso G; Tomasello F; Chiofalo MS
Circ Shock; 1992 Oct; 38(2):138-44. PubMed ID: 1423922
[TBL] [Abstract][Full Text] [Related]
6. Roles of the bacterial cell wall and capsule in induction of tumor necrosis factor alpha by type III group B streptococci.
Vallejo JG; Baker CJ; Edwards MS
Infect Immun; 1996 Dec; 64(12):5042-6. PubMed ID: 8945544
[TBL] [Abstract][Full Text] [Related]
7. Identification of a genetic locus essential for capsule sialylation in type III group B streptococci.
Wessels MR; Haft RF; Heggen LM; Rubens CE
Infect Immun; 1992 Feb; 60(2):392-400. PubMed ID: 1309720
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of tumor necrosis factor alpha and eicosanoid inhibitors in experimental models of neonatal sepsis.
Mancuso G; Cusumano V; Cook JA; Smith E; Squadrito F; Blandino G; Teti G
FEMS Immunol Med Microbiol; 1994 Jun; 9(1):49-54. PubMed ID: 7920463
[TBL] [Abstract][Full Text] [Related]
9. Identification of cpsD, a gene essential for type III capsule expression in group B streptococci.
Rubens CE; Heggen LM; Haft RF; Wessels MR
Mol Microbiol; 1993 May; 8(5):843-55. PubMed ID: 8355611
[TBL] [Abstract][Full Text] [Related]
10. Production of tumor necrosis factor by human cells in vitro and in vivo, induced by group B streptococci.
Williams PA; Bohnsack JF; Augustine NH; Drummond WK; Rubens CE; Hill HR
J Pediatr; 1993 Aug; 123(2):292-300. PubMed ID: 8345430
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of pentoxifylline in neonatal rats infected with group B streptococci.
Mancuso G; Blandino G; Gambuzza M; Genovese F; Migliardo M; Carbone M; Fera MT; Cusumano V
J Chemother; 1995 Oct; 7(5):417-9. PubMed ID: 8596123
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to tumor necrosis factor-alpha: use as adjunctive therapy in established group B streptococcal disease in newborn rats.
Givner LB; Gray L; O'Shea TM
Pediatr Res; 1995 Oct; 38(4):551-4. PubMed ID: 8559608
[TBL] [Abstract][Full Text] [Related]
13. Effect of type III group B streptococcal capsular polysaccharide on invasion of respiratory epithelial cells.
Hulse ML; Smith S; Chi EY; Pham A; Rubens CE
Infect Immun; 1993 Nov; 61(11):4835-41. PubMed ID: 8406885
[TBL] [Abstract][Full Text] [Related]
14. Capsular type-specific polysaccharide partially inhibits group B Streptococcus-induced pulmonary hypertension.
Li JX; Gray BM; Pritchard DG; Oliver JR; Grantham KD; Philips JB
Am Rev Respir Dis; 1993 Jul; 148(1):152-7. PubMed ID: 8317791
[TBL] [Abstract][Full Text] [Related]
15. Group B streptococci (GBS) injure lung endothelium in vitro: GBS invasion and GBS-induced eicosanoid production is greater with microvascular than with pulmonary artery cells.
Gibson RL; Soderland C; Henderson WR; Chi EY; Rubens CE
Infect Immun; 1995 Jan; 63(1):271-9. PubMed ID: 7806366
[TBL] [Abstract][Full Text] [Related]
16. The effect of type-specific polysaccharide capsule on the clearance of group B streptococci from the lungs of infant and adult rats.
Martin TR; Ruzinski JT; Rubens CE; Chi EY; Wilson CB
J Infect Dis; 1992 Feb; 165(2):306-14. PubMed ID: 1730897
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 production by human neonatal monocytes stimulated by type III group B streptococci.
Vallejo JG; Baker CJ; Edwards MS
J Infect Dis; 1996 Aug; 174(2):332-7. PubMed ID: 8699063
[TBL] [Abstract][Full Text] [Related]
18. Penicillin-binding proteins in Streptococcus agalactiae: a novel mechanism for evasion of immune clearance.
Jones AL; Needham RH; Clancy A; Knoll KM; Rubens CE
Mol Microbiol; 2003 Jan; 47(1):247-56. PubMed ID: 12492868
[TBL] [Abstract][Full Text] [Related]
19. Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines.
Gravekamp C; Kasper DL; Paoletti LC; Madoff LC
Infect Immun; 1999 May; 67(5):2491-6. PubMed ID: 10225912
[TBL] [Abstract][Full Text] [Related]
20. Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci.
Marques MB; Kasper DL; Pangburn MK; Wessels MR
Infect Immun; 1992 Oct; 60(10):3986-93. PubMed ID: 1398910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
